Background Severe aortic stenosis (AS) is commonly associated with advanced cardiac damage, including right ventricular dysfunction (RVD), pulmonary hypertension (PH) and tricuspid regurgitation (TR), ...
TULSA, Okla. — A new procedure at the Oklahoma Heart Institute is changing lives for people at high risk for heart surgery. "That's why it's so ground breaking and important. This is the first such ...
Irvine, Calif., Jan. 22, 2026 — University of California, Irvine and Philadelphia-based Jefferson Health researchers have identified fundamental structural and functional differences between two major ...
IRVINE, Calif.--(BUSINESS WIRE)-- Edwards Lifesciences (EW) today announced the company’s SAPIEN M3 mitral valve replacement system is the first transcatheter therapy utilizing a transseptal approach ...
Elevated transmitral mean pressure gradient (TMPG) was associated with greater risk of all-cause death and heart failure (HF) hospitalization among patients with functional mitral regurgitation (MR) ...
Mitral valve regurgitation is a heart condition that occurs when the mitral valve does not close properly, allowing blood to flow backward into the left atrium. Symptoms do not always occur. When they ...
NEW YORK CITY -- Heart valve innovation has made polymer valves a reality, with one such device boasting good 1-year outcomes in a small single-arm study. Adults who received the Tria device for ...
Background: The arcade-like mitral apparatus is a rare congenital anomaly characterized by complex subvalvular pathology, often resulting in mitral dysfunction. These anatomical complexities make ...
Impact of Prior History of Stroke on Clinical Outcomes in Patients With Severe Aortic Stenosis Following Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis Receive the the ...
There’s huge movement on the mitral valve landscape this month, as Foldax is reporting reaching a regulatory milestone for the Tria Mitral Valve. The Salt Lake City, UT-based company has won approval ...
(RTTNews) - Abbott Laboratories (ABT) announced Tuesday that the U.S. Food and Drug Administration (FDA) has approved the company's Tendyne transcatheter mitral valve replacement (TMVR) system to ...
Abbott Laboratories has received approval for a mitral valve replacement that can be implanted without open-heart surgery. The U.S. Food & Drug Administration gave the OK for the North Chicago-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results